Literature DB >> 5053812

Pharmacokinetics and biotransformation of chlorpropamide in man.

J A Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5053812     DOI: 10.1002/cpt1972135part1710

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  18 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Plasma concentrations, bioavailability and dissolution of chlorpropamide.

Authors:  T Taylor; D F Assinder; L F Chasseaud; P M Bradford; J S Burton
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

3.  The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide.

Authors:  J Kallio; R Huupponen; K Pyykkö
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  The bioavailability in man of marketed brands of chlorpropamide.

Authors:  A M Monro; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination.

Authors:  P J Neuvonen; S Kärkkäinen; R Lehtovaara
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 6.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

7.  Bioavailability of chlorpropamide.

Authors:  M Evans; R C Glass; M Mitchard; B M Munday; R Yates
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

Review 8.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

Review 9.  Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.

Authors:  A D Harrower
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

10.  Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes.

Authors:  A E Pontiroli; A De Pasqua; R Colombo; C Ricordi; G Pozza
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.